Joel Ackerman - 31 Oct 2024 Form 4 Insider Report for CHAMPIONS ONCOLOGY, INC. (CSBR)

Role
Director
Signature
/s/ Joel Ackerman
Issuer symbol
CSBR
Transactions as of
31 Oct 2024
Net transactions value
$0
Form type
4
Filing time
01 Nov 2024, 09:04:36 UTC
Previous filing
17 Sep 2024
Next filing
18 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSBR Common Stock Options Exercise $185,787 +88,470 +10% $2.10 945,467 31 Oct 2024 Direct
transaction CSBR Common Stock Options Exercise $90,502 +16,667 +1.8% $5.43 962,134 31 Oct 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CSBR Option to purchase Common Stock Options Exercise $185,787 -88,470 -100% $2.10 0 31 Oct 2024 Common Stock 88,470 $2.10 Direct F1
transaction CSBR Option to purchase Common Stock Options Exercise $90,502 -16,667 -100% $5.43 0 31 Oct 2024 Common Stock 16,667 $5.43 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were immediately exercisable upon grant on July 19, 2016.
F2 4,167 options were immediately exercisable on November 4, 2019 with the remaining options vesting and available to exercise on February 4, 2020, May 4, 2020 and August 4, 2020.